Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

54.13USD
25 Nov 2014
Price Change (% chg)

$-1.77 (-3.17%)
Prev Close
$55.90
Open
$56.25
Day's High
$56.25
Day's Low
$53.36
Volume
1,052,080
Avg. Vol
874,901
52-wk High
$56.59
52-wk Low
$38.26

Search Stocks
LANDINE MICHAEL J
Trading Date Type Shares Traded Price Shares Held
10 Nov 2014 Sell 15,000 $52.74 130,521
10 Nov 2014 Buy 15,000 $14.90 130,521
13 Oct 2014 Buy 15,000 $14.90 130,521
13 Oct 2014 Sell 15,000 $40.65 130,521
17 Sep 2014 Sell 15,000 $45.60 130,521
17 Sep 2014 Buy 15,000 $14.90 130,521
2 Jul 2014 Sell 7,000 $51.31 130,521
2 Jul 2014 Buy 6,750 $12.30 130,521
2 Jul 2014 Buy 250 $12.30 130,521
25 Jun 2014 Buy 10,000 $12.30 130,521
25 Jun 2014 Sell 10,000 $49.92 130,521
18 Jun 2014 Buy 10,000 $12.30 130,521
18 Jun 2014 Sell 10,000 $47.01 130,521
27 May 2014 Sell 814 $45.74 130,521
27 May 2014 Buy 2,500 $0.00 130,521
20 May 2014 Sell 1,221 $44.48 128,835
20 May 2014 Buy 3,750 $0.00 128,835
19 May 2014 Buy 3,750 $0.00 128,835
19 May 2014 Sell 1,221 $43.98 128,835
16 May 2014 Buy 3,250 $0.00 123,777
16 May 2014 Sell 1,058 $43.59 123,777
17 Nov 2013 Sell 2,361 $36.89 121,585
17 Nov 2013 Buy 5,000 $0.00 121,585
11 Aug 2013 Sell 1,500 $33.89 118,946
11 Aug 2013 Buy 1,500 $14.57 118,946

Institutional Holders

% Shares Owned: 97.26%
# of Holders: 273
Total Shares Held: 142,227,450
3 Mo. Net Change: 218,463
# New Positions: 23
# Closed Positions: 34
# Increased Positions: 120
# Reduced Positions: 126
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

Richard Pops

51 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

51 2011 President

James Frates

46 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

56 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

55 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Rebecca Peterson

38 Senior Vice President, Corporate Communications

Elliot Ehrich

55 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

60 2011 Senior Vice President - Corporate Development

Mark Stejbach

50 2012 Senior Vice President, Chief Commercial Officer

Paul Mitchell

61 2012 Lead Independent Director

Nancy Wysenski

56 2013 Director

David Anstice

65 2011 Independent Director

Floyd Bloom

77 2011 Independent Director

Robert Breyer

70 2011 Independent Director

Wendy Dixon

58 2011 Independent Director

Geraldine Henwood

60 2011 Independent Director
Search Stocks